Atlas Trials

A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets

Clinical trial NCT04550455 · UNKNOWN

Trial details

NCT number
NCT04550455
Sponsor
Keith Edwards, M.D.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2020-09-16
Primary completion
2024-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.